Europe Age-Related Macular Degeneration Market and Competitive Landscape - 2018

  • ID: 4630261
  • Report
  • Region: Europe
  • Fore Pharma
20 % OFF
until Dec 31st 2018
1 of 3
The latest research Europe Age-Related Macular Degeneration Market and Competitive Landscape - 2018, provides comprehensive insights into Age-Related Macular Degeneration pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Age-Related Macular Degeneration market size and drug sales. This research also provides insights into Age-Related Macular Degeneration epidemiology and late stage pipeline.

The research is classified into following sections - Age-Related Macular Degeneration overview with definitions, symptoms, etiology, diagnosis, treatment options; Age-Related Macular Degeneration pipeline insights covering late stage clinical trials pipeline; Age-Related Macular Degeneration prevalence trends by countries; Age-Related Macular Degeneration market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries - Germany, France, Italy, Spain, UK, Europe.

Research Scope:
  • Age-Related Macular Degeneration pipeline: Find out the drugs in clinical trials for Age-Related Macular Degeneration by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Age-Related Macular Degeneration epidemiology: Find out the prevalence of Age-Related Macular Degeneration by countries - Europe, Germany, France, Italy, Spain, UK; prevalence forecast to 2023
  • Age-Related Macular Degeneration products: Identify key products marketed and prescribed for Age-Related Macular Degeneration by brand name, by molecule, by company, by branded / generic, by countries - Europe, Germany, France, Italy, Spain, UK
  • Age-Related Macular Degeneration market size: Find out the market size for Age-Related Macular Degeneration drugs by countries - Europe, Germany, France, Italy, Spain, UK; Find out how the market advanced from 2014
  • Age-Related Macular Degeneration drug sales: Find out the sales of Age-Related Macular Degeneration drugs by countries - Europe, Germany, France, Italy, Spain, UK
  • Age-Related Macular Degeneration drugs sales forecast: Sales forecast for Age-Related Macular Degeneration drugs to 2023 by countries - Europe, Germany, France, Italy, Spain, UK
  • Age-Related Macular Degeneration market share analysis: Find out the market shares of Age-Related Macular Degeneration drugs and outlook by countries - Europe, Germany, France, Italy, Spain, UK
Benefits of this Research:
  • Evaluate commercial market opportunities for Age-Related Macular Degeneration drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Age-Related Macular Degeneration market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Age-Related Macular Degeneration market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Age-Related Macular Degeneration: Disease Overview
1.1. Age-Related Macular Degeneration Symptoms
1.2. Age-Related Macular Degeneration Etiology
1.3. Age-Related Macular Degeneration Diagnosis
1.4. Age-Related Macular Degeneration Treatment Options

2. Age-Related Macular Degeneration Pipeline Insights
2.1. Age-Related Macular Degeneration Phase 3 Clinical Trials
2.2. Age-Related Macular Degeneration Phase 2 Clinical Trials
2.3. Age-Related Macular Degeneration Phase 1 Clinical Trials

3. Age-Related Macular Degeneration Epidemiology Analysis

4. Germany Age-Related Macular Degeneration Market Insights
4.1. Marketed Products for Age-Related Macular Degeneration in Germany
4.2. Germany Age-Related Macular Degeneration Market Size & Forecast
4.3. Germany Age-Related Macular Degeneration Product Sales Forecast
4.4. Germany Age-Related Macular Degeneration Market Share Analysis

5. France Age-Related Macular Degeneration Market Insights
5.1. Marketed Products for Age-Related Macular Degeneration in France
5.2. France Age-Related Macular Degeneration Market Size & Forecast
5.3. France Age-Related Macular Degeneration Product Sales Forecast
5.4. France Age-Related Macular Degeneration Market Share Analysis

6. Italy Age-Related Macular Degeneration Market Insights
6.1. Marketed Products for Age-Related Macular Degeneration in Italy
6.2. Italy Age-Related Macular Degeneration Market Size & Forecast
6.3. Italy Age-Related Macular Degeneration Product Sales Forecast
6.4. Italy Age-Related Macular Degeneration Market Share Analysis

7. Spain Age-Related Macular Degeneration Market Insights
7.1. Marketed Products for Age-Related Macular Degeneration in Spain
7.2. Spain Age-Related Macular Degeneration Market Size & Forecast
7.3. Spain Age-Related Macular Degeneration Product Sales Forecast
7.4. Spain Age-Related Macular Degeneration Market Share Analysis

8. UK Age-Related Macular Degeneration Market Insights
8.1. Marketed Products for Age-Related Macular Degeneration in UK
8.2. UK Age-Related Macular Degeneration Market Size & Forecast
8.3. UK Age-Related Macular Degeneration Product Sales Forecast
8.4. UK Age-Related Macular Degeneration Market Share Analysis

9. Europe Age-Related Macular Degeneration Market Insights
9.1. Europe Age-Related Macular Degeneration Market Size & Forecast
9.2. Europe Age-Related Macular Degeneration Product Sales Forecast
9.3. Europe Age-Related Macular Degeneration Market Share Analysis

10. Research Methodology

List of Tables
Table 1: Age-Related Macular Degeneration Phase 3 Clinical Trials, Global, 2018
Table 2: Age-Related Macular Degeneration Phase 2 Clinical Trials, Global, 2018
Table 3: Age-Related Macular Degeneration Phase 1 Clinical Trials, Global, 2018
Table 4: Age-Related Macular Degeneration Prevalence by EU5 Countries, 2014 - 2023
Table 5: Marketed Products for Age-Related Macular Degeneration in Germany, 2017
Table 6: Germany Age-Related Macular Degeneration Market Size & Forecast ($mn), 2014 - 2023
Table 7: Germany Age-Related Macular Degeneration Product Sales ($mn), 2014 - 2023
Table 8: Germany Age-Related Macular Degeneration Market Trends, 2014 - 2023
Table 9: Marketed Products for Age-Related Macular Degeneration in France, 2017
Table 10: France Age-Related Macular Degeneration Market Size & Forecast ($mn), 2014 - 2023
Table 11: France Age-Related Macular Degeneration Product Sales ($mn), 2014 - 2023
Table 12: France Age-Related Macular Degeneration Market Trends, 2014 - 2023
Table 13: Marketed Products for Age-Related Macular Degeneration in Italy, 2017
Table 14: Italy Age-Related Macular Degeneration Market Size & Forecast ($mn), 2014 - 2023
Table 15: Italy Age-Related Macular Degeneration Product Sales ($mn), 2014 - 2023
Table 16: Italy Age-Related Macular Degeneration Market Trends, 2014 - 2023
Table 17: Marketed Products for Age-Related Macular Degeneration in Spain, 2017
Table 18: Spain Age-Related Macular Degeneration Market Size & Forecast ($mn), 2014 - 2023
Table 19: Spain Age-Related Macular Degeneration Product Sales ($mn), 2014 - 2023
Table 20: Spain Age-Related Macular Degeneration Market Trends, 2014 - 2023
Table 21: Marketed Products for Age-Related Macular Degeneration in UK, 2017
Table 22: UK Age-Related Macular Degeneration Market Size & Forecast ($mn), 2014 - 2023
Table 23: UK Age-Related Macular Degeneration Product Sales ($mn), 2014 - 2023
Table 24: UK Age-Related Macular Degeneration Market Trends, 2014 - 2023
Table 25: Europe Age-Related Macular Degeneration Market Size & Forecast ($mn), 2014 - 2023
Table 26: Europe Age-Related Macular Degeneration Product Sales ($mn), 2014 - 2023

List of Figures
Figure 1: Age-Related Macular Degeneration Pipeline by Phase (%), Global, 2018
Figure 2: Age-Related Macular Degeneration Prevalence by EU5 Countries, 2014 - 2023
Figure 3: Germany Age-Related Macular Degeneration Market Size ($mn), 2014 - 2023
Figure 4: Germany Age-Related Macular Degeneration Product Sales ($mn), 2014 - 2023
Figure 5: Germany Age-Related Macular Degeneration Market Share by Products (%), 2017
Figure 6: Germany Age-Related Macular Degeneration Market - Future Market Share (%), 2023
Figure 7: France Age-Related Macular Degeneration Market Size ($mn), 2014 - 2023
Figure 8: France Age-Related Macular Degeneration Product Sales ($mn), 2014 - 2023
Figure 9: France Age-Related Macular Degeneration Market Share by Products (%), 2017
Figure 10: France Age-Related Macular Degeneration Market - Future Market Share (%), 2023
Figure 11: Italy Age-Related Macular Degeneration Market Size ($mn), 2014 - 2023
Figure 12: Italy Age-Related Macular Degeneration Product Sales ($mn), 2014 - 2023
Figure 13: Italy Age-Related Macular Degeneration Market Share by Products (%), 2017
Figure 14: Italy Age-Related Macular Degeneration Market - Future Market Share (%), 2023
Figure 15: Spain Age-Related Macular Degeneration Market Size ($mn), 2014 - 2023
Figure 16: Spain Age-Related Macular Degeneration Product Sales ($mn), 2014 - 2023
Figure 17: Spain Age-Related Macular Degeneration Market Share by Products (%), 2017
Figure 18: Spain Age-Related Macular Degeneration Market - Future Market Share (%), 2023
Figure 19: UK Age-Related Macular Degeneration Market Size ($mn), 2014 - 2023
Figure 20: UK Age-Related Macular Degeneration Product Sales ($mn), 2014 - 2023
Figure 21: UK Age-Related Macular Degeneration Market Share by Products (%), 2017
Figure 22: UK Age-Related Macular Degeneration Market - Future Market Share (%), 2023
Figure 23: Europe Age-Related Macular Degeneration Market Size ($mn), 2014 - 2023
Figure 24: Europe Age-Related Macular Degeneration Product Sales ($mn), 2014 - 2023
Figure 25: Europe Age-Related Macular Degeneration Market Share by Products (%), 2017
Figure 26: Europe Age-Related Macular Degeneration Market - Future Market Share (%), 2023
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll